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Abstract
Background: Complex traits like cancer, diabetes, obesity or schizophrenia arise from an intricate interaction
between genetic and environmental factors. Complex disorders often cluster in families without a clear-cut pattern
of inheritance. Genomic wide association studies focus on the detection of tens or hundreds individual markers
contributing to complex diseases. In order to test if a subset of single nucleotide polymorphisms (SNPs) from
candidate genes are associated to a condition of interest in a particular individual or group of people, new
techniques are needed. High-resolution melting (HRM) analysis is a new method in which polymerase chain
reaction (PCR) and mutations scanning are carried out simultaneously in a closed tube, making the procedure fast,
inexpensive and easy. Preterm birth (PTB) is considered a complex disease, where genetic and environmental
factors interact to carry out the delivery of a newborn before 37 weeks of gestation. It is accepted that
inflammation plays an important role in pregnancy and PTB.
Methods: Here, we used real time-PCR followed by HRM analysis to simultaneously identify several gene variations
involved in inflammatory pathways on preterm labor. SNPs from TLR4, IL6, IL1 beta and IL12RB genes were
analyzed in a case-control study. The results were confirmed either by sequencing or by PCR followed by
restriction fragment length polymorphism.
Results: We were able to simultaneously recognize the variations of four genes with similar accuracy than other
methods. In order to obtain non-overlapping melting temperatures, the key step in this strategy was primer
design. Genotypic frequencies found for each SNP are in concordance with those previously described in similar
populations. None of the studied SNPs were associated with PTB.
Conclusions: Several gene variations related to the same inflammatory pathway were screened through a new
flexible, fast and non expensive method with the purpose of analyzing their association to PTB. It can easily be
used for simultaneously analyze any set of SNPs, either as the first choice for new association studies or as a
complement to large-scale genotyping analysis. Given that inflammatory pathway is in the base of several diseases,
it is potentially useful to analyze a broad range of disorders.
Background
Complex traits like cancer, diabetes, obesity or schizo-
phrenia arise from an intricate interaction of genetic
and environmental factors. Genetic bases of complex
disorders are usually difficult to determine due to the
fact that environmental factors such as life style and
their epigenetic consequences are molding the
development of the disease. It is proposed that these
factors mask the patterns of inheritance.
Preterm birth (PTB) is considered a complex disease,
where genetics and environmental factors interact to
lead to an undesirable effect which is the delivery of a
newborn before 37 weeks of gestation [1,2]. PTB com-
plicates many pregnancies and has for decades been
strongly associated with increased risk of neonatal mor-
bidity and mortality [3]. As a multifactorial trait, mater-
nal stress, multiple pregnancies, exposure to toxics
during pregnancy and genetic predisposition are well-
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accepted that inflammation plays an important role in
pregnancy and in PTB [5-7]. An altered inflammatory
activity due to functionally relevant polymorphisms of
the innate immune system may influence pathways lead-
ing to PTB and, therefore, impact on its frequency and/
or severity.
Post genomic era and high-throughput techniques like
genome-wide association studies (GWAS) yield informa-
tion on millions of single nucleotide polymorphisms
(SNPs) distributed across the human genome, to inden-
tify candidate genes involved in complex diseases [8,9].
Later, fewer SNPs should be replicated in different
populations to confirm the results, implying the need of
a middle throughput platform to fulfill the study
requirements [10]. In addition, clinical applications after
a GWAS should comprise testing the candidate SNPs in
a particular individual or a small group of people. Thus,
there is a pressing need for multi-SNP analysis methods
that can reveal system-level differences in candidate
patients that are suspected of suffering a particular
condition.
Several SNP genotyping techniques had been devel-
oped, such as PCR followed by restriction fragment
length polymorphism (RFLP), direct sequencing, or
PCR-based TaqMan chemistry. Some of these techni-
ques are either expensive or permit only one SNP per
assay, meaning there are laborious and time-consuming.
High-resolution melting (HRM) analysis is a new and
rapid method for mutation detection, in which polymer-
ase chain reaction (PCR) and mutations scanning are
carried out simultaneously in a single procedure [11].
Genotyping by high-resolution amplicon melting is
achieved with a post-PCR short melting step and uses a
next generation saturating double-stranded DNA bind-
ing dye. The amplicon melting profile depends on its
length, GC content, sequence characteristics and hetero-
zygosity. This approach provides a simple, closed-tube
detection that can easily detect heteroduplexes as well
as homoduplexes based on their characteristic melting
curve profiles [12].
In the present study, we used HRM analysis to simul-
taneously identify mutations in four genes involved on
inflammatory pathways. Genotype data from preterm
newborns were compared to data acquired from those
born at term. In particular, quadruplex amplicon geno-
typing by HRM analysis was developed to rapidly iden-
tify the allele frequencies of four SNPs related to
inflammatory response.
Methods
Study samples and DNA extraction
Subjects in this study were unrelated offspring of
women receiving obstetrical care at the Pereira Rossell
Hospital Center, Montevideo, Uruguay. Mothers with a
history of drug abuse, chronic inflammatory diseases or
twin pregnancy were excluded. The study protocol was
approved by the School of Medicine’s Ethics Committee
of the University of the Republic, Uruguay. Mothers
were inquired regarding sociodemographic characteris-
tics, obstetric history, and data from the newborn
through a specific designed questionnaire. Study popula-
tion characteristics were previously detailed in Rey et al.
[13]. Informed written consent was obtained from
mothers prior to collection of biological material.
Whole-blood samples from 56 subjects born at term
and 53 born preterm were extracted and DNA isolated
using DNeasy Blood and Tissue kit (Qiagen, Hilden,
Germany). Each DNA sample was checked under an UV
spectrophotometer (Biophotometa, Eppendorf, Ham-
burg, Germany).
SNP selection, primer design and real time PCR
conditions
In order to test the capability of HRM analysis to dis-
tinguish variable types of SNPs, four different candi-
date genes were chosen based of several criteria: (1)
SNPs that are common in the study population (minor
allele frequency around 5%-10%), bearing in mind that
ethnic variation in allele frequencies does exist; (2)
SNPs with potential functional consequences (func-
tional SNPs) that are likely to alter the expression
levels (regulatory SNPs) or protein folding structure
(non-synonymous SNPs); (3) SNPs that capture the
variation across a gene and can be used later to assign
a haplotype [14] and (4) SNPs with a potential role in
the inflammatory cascade as well as interaction to
environmental factors. The selected SNPs were:
rs4986790 (Toll like receptor 4 (TLR4) gene), rs16944
(interleukin 1b (IL-1b gene), rs1800795 (interleukin 6
(IL6) genes) and rs375947 (Interleukin 12 Receptor B
(IL12RB) gene).
Several pairs of primer sets were designed for the
aforementioned SNPs based in their flanking
sequences using Primer3 tool (http://frodo.wi.mit.edu/
primer3/). We created amplicons with non-overlap-
ping melting temperatures and smaller than 250 pb, to
have higher sensibility in the HRM analysis. Following
Seipp et al. [15] recommendations some of the pri-
mers were designed with the inclusion of either GC-
or AT-tails in order to modify the amplicon’sm e l t i n g
temperature (Tm).
Real time PCR and high-resolution-melting analysis
HRM analysis was performed on the Rotor-Gene 6000™
real-time instrument (Corbett Life Science, Sydney, Aus-
tralia) with Eva Green, a saturating dye technology
(Type-it HRM PCR Kit, Qiagen, Hilden, Germany).
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amplicon reaction and then quadruplex amplification
was optimized. To set up the multiplex reaction, primer
concentrations were determined empirically. First, each
amplicon was amplified individually using the same PCR
conditions to identify its Tm and efficiency in genotyp-
ing with HRM. Secondly, multiplex HRM analysis was
performed in equimolar concentrations of the four pair
of primers. At last, primer concentrations were adjusted
according to the size of the peak obtained: primers
yielding amplicons with lowest peaks were augmented
and vice-versa. In this way, primer concentrations were
adjusted to equalize signal from all amplicons.
Finally, PCRs were performed in 10 μl reaction
volumes, containing 1X Qiagen HRM-typing buffer, 2.46
μM of each TLR4 gene primer, 0.46 μM of each IL6
gene primer, 0.26 μMo fe a c hI L 1 b gene primer, 0.9 μM
of each IL12RB gene primer and 25 ng of template
DNA. PCR reaction was carried out with an initial hold
at 95°C for 5 min, followed by 35 cycles of 95°C for 15 s
and 60°C for 1 min, and then HRM ramps were gener-
ated by acquiring fluorescence data at a temperature
ramp from 72 to 88°C. Individuals with homozygous
and heterozygous genotypes were included as controls
in all experiments.
HRM curves were normalized and genotype was
assigned according to HRM curve shape by the Rotor-
Gene software and visual inspection. Melting curves
observed were analyzed separately for each amplicon in
the software to assign genotypes to samples.
Restriction fragment length polymorphism (RFLP) and
sequencing
To corroborate genotype assignment, we performed a
blinded study based on a subset of samples genotyped
with PCR-RFLP assays. rs4986790 was analyzed using
mismatched primers as described by Lorenz et al. [16].
rs16944 was analyzed according to Di Giovine et al.
[17]. rs1800795 was amplified using same specific newly
designed primer set employed in the real time PCR with
the following conditions: 94°C for 5 min, then 35 cycles
of 94°C for 30 s, 62°C for 30 s, 72°C for 30 s, and a final
extension at 72°C for 5 min. The products were digested
with 5 U of Hin1II (Fermentas Inc.) in a final volume of
20 μl at 37°C for 2 h. For rs375947 a modified protocol
of Lee et al. [18] was employed, consisting in a double
digestion with 5 U of Hin1II at 37°C for 2 h followed by
a digestion with 10 U of TaqI at 65°C for 12 h. In all
cases fragments were analyzed by electrophoresis on a
1.5% high-resolution agarose gel and stained with ethi-
dium bromide for visualization.
A random subset of PCR samples for the four genes
was also sequenced using the BigDye Direct Sequencing
kit (Applied Biosystem).
Statistical analyses
All SNPs were tested for Hardy-Weinberg disequili-
brium with an exact test. Case-control association tests
were performed using c
2 test and the significance of
associations between genotypes and PTB were assessed
using logistic regression. Statistical analyses were per-
formed with PLINK v1.07 [19].
Results
HRM settings
Designed conditions allowed obtaining a four-amplicon
multiplex real-time PCR (Figure 1). The primers that
best fitted conditions in order to obtain a four amplicon
multiplex are indicated in Table 1. Temperature of
melting (Tm) of amplicons is clearly separated from
each other without overlap, spanning a 12°C tempera-
ture range. Amplicon with lowest Tm corresponds to
rs4986790 (Tm = 75.5°C), in which we found the homo-
zygous genotype AA and heterozygous AG (Figure 2A).
Second amplicon is rs1800795 with Tm = 78°C and only
homozygous GG and heterozygous CG genotypes were
found (Figure 2B). For rs16944 (Tm = 83°C) (Figure 2C)
and rs375947 (Tm = 85°C) (Figure 2D) all three geno-
types where observed in each case.
Genotype assignment
rs4986790, rs1800795, rs16944 and rs375947 genotypes
were correctly assigned from HRM curves observed in
the Rotor-Gene software, using sequenced samples
included as control genotypes as reference for assign-
ment in all runs. Only 2 samples out of 109 could not
be confidently genotyped by multiplex HRM in the case
of rs375947 (Additional file 1).
Allelic frequencies were calculated for each SNP
(Table 2). Hardy-Weinberg (H-W) disequilibrium exact
test indicates that SNPs rs16944, rs4986790, rs1800795
are in Hardy-Weinberg equilibrium (p > 0.05), whereas
rs375947, located in IL12RB gene, is not. Particularly, if
case and control groups are discerned, H-W disequili-
brium test for rs375947 indicates control individuals are
in H-W equilibrium, while case individuals are not
(Table 2). No significant association was found between
term and preterm newborns, for the analyzed SNPs (p >
0.05; Table 2).
Genotype verification
The accuracy of the genotyping results was confirmed
by RFLP and/or sequencing of the PCR product in a
blinded study, for which random samples from our
data study were used (Additional file 2). rs375947
( I L 1 2 R B )w a sa s s a y e db ym e a n so fad o u b l ed i g e s t i o n
with restriction enzymes in a set of random indivi-
duals. The procedure was a modification of the strat-
egy used by Lee et al. [18] and obtained a better
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amplicon is a 487 bp length fragment and was digested
with Hin1II and TaqI. The TaqI restriction site is loca-
lized at 311 bp from the 5’ end. TaqI restriction site is
a non polymorphic restriction site that allows distin-
guishing the fragments generated by Hin1II. When the
4 8 7b pf r a g m e n ti sd i g e s t e db yH i n 1 I I ,an o np o l y -
morphic restriction site is localized at 243 bp from the
5’ end. A second Hin1II restriction site exists at 213
pb from the 5’end only at the SNP’s mayor allele. After
digestion with both enzymes, heterozygous SNPs yield
a band pattern with 243, 216, 176, 68 and 27 bp frag-
ments. Meanwhile, homozygotes are recognized
because of the absence of the bands of 216 and 27 pb
in the case of GG genotype (band pattern: 243 pb, 176
pb and 68 pb); or the absence of 243 bp in the case of
AA (band pattern: 216 pb, 176 pb, 68 pb and 27 pb)
(Figure 3).
Conditions that affected the efficiency of the
multiplex PCR
Design and concentration of primers proved to be the
key step in this technique. Primers that generated ampli-
cons between 50 to 250 bp and that were designed to
avoid having more than one SNP per amplicon got the
higher HRM efficiency. Efficiency is defined by the abil-
ity to discern and call different genotypes. Amplicons
with no-overlapping Tm’s are an absolute requirement
to be able to distinguish between the variants in a multi-
plex HRM analysis. In order to modify an amplicon’s
Tm it is more effective to design primers with varying
lengths than to design modified primers. The inclusion
o fG C -o rA T - t a i l si nt h ep r i m e r s( a si nS e i p pe ta l .
[15]) did not notoriously affect amplicon’sT mi nt h i s
particular multiplex.
As expected, quality and concentration of the DNA
sample influenced multiplex efficiency. Software
Table 1 Primer sequences and amplicon information for the quadruplex HRM PCR assay
SNP reference number Gene Chromosome Primer sequence (5’-> 3’) PCR product size (bp) Primer concentration
in multiplex PCR (μM)
rs4986790 TLR4 9 F ATTTGACCATTGAAGAATTCCG 157 2.46
R TGTTGCCATCCGAAATTATAAG
rs1800795 IL6 7 F GCCTCAATGACGACCTAAGC 105 0.46
R GGGGCTGATTGGAAACCTTA
rs16944 IL1b 2 F CTTGGGTGCTGTTCTCTGCCTC 126 0.26
R CAACTCCGTCAGGAGCCTGAAC
rs375947 IL12RB 19 F CTGCCATTCAATGCAATACG 241 0.9
R CCCTGTAGGGTCAGGGGTAT
Figure 1 Representative quadruplex melting curves obtained by HRM. The melting peaks correspond to rs4986790 (TLR4), rs1800795 (IL6),
rs16944 (IL-1b) and rs375947 (IL12RB) as temperature increases.
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racy when DNA sample had an OD 260/280 ratio within
the normal range (1.8-2.0) and a concentration of 50 ng/
μL or higher. However, if some of these conditions were
not met, the use of visual inspection of the curves
allowed a correct assignment of the genotype in most
cases.
Results can be viewed and genotype assigned as either
a melting plot or a normalized difference plot as pre-
sented in the Rotor-Gene software, being the former
one the most informative (Additional file 3).
Discussion
In this study, we developed a quadruplex real-time
HRM -PCR test which allows rapid and reliable SNP
genotyping. Applying this technique, we were able to
efficiently genotype variations in four inflammation-
related genes at the same time in a case-control study
population. The accuracy of the test was successfully
verified through independent techniques such as PCR-
RFLP and/or sequencing.
Multiplex HRM strategy has many important advan-
tages. Unlike conventional genotyping methods, this
assay does not require post PCR manipulations, saving
time and reducing contamination risk. In addition, in
quadruplex amplification such as the one designed here,
assay costs are greatly reduced by analyzing four SNPs
simultaneously. We have also showed that common oli-
gonucleotide pairs can be used in this analysis, hence
reducing optimization time. Thus, additional modifica-
tions to change amplicon’s Tm, as proposed by Seipp et
al. [15], are not needed. Primer design is a key step in
this strategy. Recently, a multiple SNP HRM genotyping
assay was presented, but the authors measured different
SNPs in the same amplicon [20]. In our case, we specifi-
cally avoided more than one SNP in each amplicon.
Potentially, two SNPs could give 9 different combined
signals for the same amplicon, distorting the other SNP
Table 2 Allelic frequencies for each analyzed SNP in cases and controls.
SNP Minor allele MAF in cases MAF in controls P-values HWE OR P-values OR
rs4986790 G 0.0472 0.0179 1 2.81 0.2291
rs1800795 C 0.1698 0.1429 0.0691 1.29 0.5441
rs16944 A 0.3962 0.4018 0.4262 0.98 0.93
rs375947 G 0.3023 0.3571 0.0002 0.84 0.5232
Statistical significance for the Hardy-Weinberg test (p-value H-W equilibrium) and Odd Ratios (OR) based on a logistic regression. MAF: Minor Allele Frequency.
Figure 2 Normalized HRM denaturation profile for all SNPs analyzed. A) rs4986790 (TLR4). Red: Homozygote AA. Blue: Heterozygote AG. B)
rs1800795 (IL6). Red: Homozygote GG. Blue: Heterozygote CG. C) rs16944 (IL-1b). Red: Homozygote GG. Blue: Heterozygote AG. Green:
Homozygote AA. D) rs375947 (IL12RB). Red: Homozygote AA. Green: Heterozygote AG. Blue: Homozygote GG.
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to separate curves in HRM from different amplicons
and four SNPs seems to be the present limit for this
technology [21,22].
Rotor-Gene platform is commonly used to perform
HRM analysis (e.g. [23,24]); however, no quadruplex
amplification had been reported in this instrument. A
quadruplex PCR was previously reported in the LightCy-
cler-32 platform, but this could not be reproduced in
other instruments [15]. Here, we have designed the first
report of a multiplex HRM genotyping assay in a Rotor-
Gene platform.
Genotyping was straightforward in all SNPs, with
homozygous HRM profiles differing from heterozygous
i nc u r v es h a p e ,w h i l et h ed i f f e r e n th o m o z y g o t e sb e i n g
easily distinguished because of their Tm shift.
I n t e r e s t i n g l y ,i nt h i ss t u d yw ew e r en o ta b l et of i n d
some of the variants already reported by other authors.
Namely, we were not able to identify the minor homo-
zygote genotype (CC) for rs1800795 (IL6) or the GG
genotype for rs4986790 (TLR4) in our study population.
It is reported that it may be difficult to distinguish com-
mon homozygotes from rare homozygotes in HRM for
some SNPs [24], which could explain this situation.
However, we independently assayed a subset of samples
with PCR-RFLP and/or sequencing, finding most geno-
typing calls identical to those made based on HRM
results, suggesting that those variants are more likely
not present in the analyzed subjects. The absence of
such genotypes could be attributed to the limited sam-
ple size in our analysis, but could also be explained by
different allele frequencies present here in comparison
to other populations. Previously, Rey et al. [13] screened
over 400 patients from a Uruguayan sample genotyping
SNP rs4986790 (TLR4) without finding the rare homo-
zygote, indicating this genotype is present in low fre-
quency in this population. On the other hand,
HAPMAP data revealed that rs4986790 GG genotype is
very rare in nearly all studied populations. Moreover,
although the CC genotype for the rs1800795 (IL6) is
present in 30% in the European population, it is absent
in the Mexican population (Table 3). Uruguayan and
Mexican populations have a similar genetic structure
Table 3 Genotype frequencies for each analyzed SNP in
Europe (CEU), Japan (JPT), Yoruba (YRI), Mexican (MXC)
populations and the Uruguayan sample *
Population SNP Gene Genotype Genotype Genotype
rs4986790 TLR4 A|A A|G G|G
CEU 0.933 0.067
JPT 1
YRI 0.933 0.067
MXC 0.939 0.061
This study 0.936 0.064
rs1800795 IL6 C|C C|G G|G
CEU 0.305 0.458 0.237
JPT 1
YRI 1
MXC 0.320 0.680
This study 0.312 0.688
rs16944 IL1b A|A A|G G|G
CEU 0.145 0.4 0.455
JPT 0.222 0.444 0.333
YRI 0.321 0.491 0.189
MXC 0.240 0.520 0.240
This study 0.138 0.523 0.339
rs375947 IL12RB A|A A|G G|G
CEU 0.383 0.483 0.133
JPT 0.364 0.5 0.136
YRI 0.567 0.4 0.033
MXC 0.720 0.280
This study 0.541 0.259 0.200
* HapMap frequencies < 0.01 are not indicated
Figure 3 Digested rs375947 (IL12RB) electrophoresis patterns
for each genotype. Genotypes are marked in each well. M:
molecular weight marker.
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Americans [25], which could be explaining the frequen-
cies shown in Table 3. Taking all these data together, it
is more likely that the absence of the rare homozygote
in our study could be related to allele architecture in
the population and not to HRM technical limitations.
The developed assay focuses on variants related to
inflammatory pathways, involved in host defense
mechanisms, innate immunity activation and infection,
as indicated in some of the web-based reference data-
bases that link the genome to biologic systems (Kyoto
Encyclopedia of Genes and Genomes, http://www.gen-
ome.jp/kegg/pathway.html; http://www.genome.jp/kegg-
bin/show_pathway?map04620). For instance, the non-
synonymous TLR4 SNP analyzed here (rs4986790) has
been associated with differences in lipopolysaccharide
responsiveness and predisposition to complex diseases
like atherogenesis, respiratory dysfunction and preterm
birth [26-29]. IL-6 -174 (rs1800795) G allele carriers
produce higher levels of IL-6 than those with the CC
genotype, and have a higher prevalence of systemic juve-
nile-onset chronic arthritis, lipid abnormalities and insu-
lin resistance [30,31]. Also, analyzed SNP in the IL-1b
gene promoter (rs16944) affects IL-1b expression and is
associated with increased risk of cancer and preterm
birth [32,33]. The protein encoded by IL12RB gene is a
type I transmembrane protein that belongs to the hemo-
poietin receptor superfamily. The lack of expression of
this gene was found to result in the immunodeficiency
of patients with severe mycobacterial and Salmonella
infections [34], and particularly, the rs375947 SNP is
associated with atopic dermatitis [35]. Likewise, using
other biological databases which identify SNPs asso-
ciated to a particular condition, this multiplex HRM
method could be potentially applied to analyze the risk
to suffer the trait of interest of both patients and
populations.
Although over the last years, high-resolution SNP
genotyping arrays have greatly facilitated the identifica-
tion of major genetic risk factors underlying complex
diseases, such major genes seem to be rare. Instead,
there is growing evidence that rare alleles and evolu-
tionarily short-lived mutations play a major role in the
etiology of complex disorders, which seem to be far
more heterogeneous than previously assumed [36].
Dissection of complex disorders into many separate
entities could greatly increase the chances for under-
standing the underlying pathogenetic mechanisms; for
example, by defining novel candidate genes that are
part of the same pathway [36]. Given that inflamma-
tion has been implicated in the mechanisms responsi-
ble for preterm and term parturition [5,6], screening of
the chosen SNPs is a reasonable strategy to understand
both mechanisms. Even more, inflammatory and
immunological aspects are postulated to be on the
base of several complex diseases others than PTB like
atherogenesis, cancer, metabolic affections, endocrino-
phatys and even obesity [37-39]. Thus, as SNPs
selected here are situated in genes related to an
inflammatory pathway, we describe a potential tool to
confident and rapidly screen gene variations that are
common to a broad range of disorders.
Multiplex analysis by HRM could also be an accurate
and reliable method for mutation detection in known
genes after the identification of particular variations
through the powerful existing strategies for elucidating
genetic variations, such as array methods, whole-genome
screening for copy number variation and high-through-
put and low-cost sequencing.
Conclusions
Several gene variations related to the same inflammatory
pathway were screened with the purpose of analyzing their
association to preterm birth. Multiplex HRM analysis has
proved to be a flexible, fast and non expensive tool. It can
easily be used for any set of SNPs, either as the first choice
for new association studies or as a complement to large-
scale genotyping analysis. It should be considered as a reli-
able genotyping technique for low or middle throughput
projects. At last, the developed method can now be
employed to assay genetic associations to preterm birth
through a larger scale population study.
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Additional file 1: Genotype call by HRM for all newborns. Multiplex
HRM assigned data to all samples ND: no data.
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HRM, RFLP and sequencing.
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Homozygote GG. Blue: Heterozygote AG. Green: Homozygote AA. B)
Normalized difference plot for rs16944 (IL1b), genotype AG as a
reference.
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